Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2025-12-29 @ 7:49 PM
Study NCT ID:
NCT00599469
Status:
UNKNOWN
Last Update Posted:
2009-08-17
First Post:
2008-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Far Infrared Treatment for Alzheimer's Disease
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000544', 'term': 'Alzheimer Disease'}, {'id': 'D058225', 'term': 'Plaque, Amyloid'}], 'ancestors': [{'id': 'D003704', 'term': 'Dementia'}, {'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D024801', 'term': 'Tauopathies'}, {'id': 'D019636', 'term': 'Neurodegenerative Diseases'}, {'id': 'D019965', 'term': 'Neurocognitive Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}, {'id': 'D020763', 'term': 'Pathological Conditions, Anatomical'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 4}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2008-02'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2009-08', 'completionDateStruct': {'date': '2009-04', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2009-08-14', 'studyFirstSubmitDate': '2008-01-11', 'studyFirstSubmitQcDate': '2008-01-11', 'lastUpdatePostDateStruct': {'date': '2009-08-17', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-01-23', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2009-03', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': "Management and Cure of Alzheimer's Disease", 'timeFrame': '1 year'}], 'secondaryOutcomes': [{'measure': 'Management and Cure of Dementia', 'timeFrame': '1 year'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Acute Confusional Senile Dementia', 'Alzheimer Type Senile Dementia', 'SENILE PLAQUES', 'NEUROFIBRILLARY TANGLES', 'NEUROPIL THREADS'], 'conditions': ['Alzheimer Disease']}, 'descriptionModule': {'briefSummary': "Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.", 'detailedDescription': "Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal.\n\nAlzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* People with Alzheimer's disease\n\nExclusion Criteria:\n\n* None"}, 'identificationModule': {'nctId': 'NCT00599469', 'briefTitle': "Far Infrared Treatment for Alzheimer's Disease", 'organization': {'class': 'OTHER', 'fullName': 'GAAD Medical Research Institute Inc.'}, 'officialTitle': "Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.", 'orgStudyIdInfo': {'id': 'GAAD-AD-CTP1'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'OTHER', 'label': '1', 'description': 'Far Infrared Radiation', 'interventionNames': ['Radiation: Far Infrared Radiation (5μm to 20μm wavelength)']}], 'interventions': [{'name': 'Far Infrared Radiation (5μm to 20μm wavelength)', 'type': 'RADIATION', 'description': 'Far Infrared radiation for 30 to 40 minutes per treatment session.', 'armGroupLabels': ['1']}]}, 'contactsLocationsModule': {'locations': [{'zip': 'M4V 1L5', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'The Centre for Incurable Diseases', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}], 'overallOfficials': [{'name': 'Ken Nedd, M.D.', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'GAAD Medical Research Institute Inc.'}, {'name': 'Kwasi Donyina, Ph.D.', 'role': 'STUDY_DIRECTOR', 'affiliation': 'GAAD Medical Research Institute Inc.'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'GAAD Medical Research Institute Inc.', 'class': 'OTHER'}, 'responsibleParty': {'oldNameTitle': 'Dr. Kwasi Donyina/Founder and President', 'oldOrganization': 'GAAD Medical Research Institute Inc.'}}}}